TY - JOUR AU - Patel, T. PY - 2002 DA - 2002// TI - Worldwide trends in mortality from biliary tract malignancies JO - BMC Cancer VL - 2 UR - https://doi.org/10.1186/1471-2407-2-10 DO - 10.1186/1471-2407-2-10 ID - Patel2002 ER - TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - JOUR AU - Fitzmaurice, C. AU - Akinyemiju, T. F. AU - Lami, F. H. AU - Alam, T. AU - Alizadeh-Navaei, R. AU - Allen, C. PY - 2018 DA - 2018// TI - Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 Cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2018.2706 DO - 10.1001/jamaoncol.2018.2706 ID - Fitzmaurice2018 ER - TY - JOUR AU - Ishihara, S. AU - Horiguchi, A. AU - Miyakawa, S. AU - Endo, I. AU - Miyazaki, M. AU - Takada, T. PY - 2016 DA - 2016// TI - Biliary tract cancer registry in Japan from 2008 to 2013 JO - J Hepatobiliary Pancreat Sci VL - 23 UR - https://doi.org/10.1002/jhbp.314 DO - 10.1002/jhbp.314 ID - Ishihara2016 ER - TY - JOUR AU - Kudo, M. AU - Izumi, N. AU - Ichida, T. AU - Ku, Y. AU - Kokudo, N. AU - Sakamoto, M. PY - 2016 DA - 2016// TI - Report of the 19th follow-up survey of primary liver cancer in Japan JO - Hepatol Res VL - 46 UR - https://doi.org/10.1111/hepr.12697 DO - 10.1111/hepr.12697 ID - Kudo2016 ER - TY - JOUR AU - Horgan, A. M. AU - Amir, E. AU - Walter, T. AU - Knox, J. J. PY - 2012 DA - 2012// TI - Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.40.5381 DO - 10.1200/JCO.2011.40.5381 ID - Horgan2012 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Moore, M. J. AU - Cox, T. F. AU - Valle, J. W. AU - Palmer, D. H. AU - McDonald, A. C. PY - 2012 DA - 2012// TI - Effect of adjuvant chemotherapy with fluorouracil plus Folinic acid or gemcitabine vs observation on survival in patients with resected Periampullary adenocarcinoma: the ESPAC-3 Periampullary Cancer randomized trial JO - JAMA VL - 308 UR - https://doi.org/10.1001/jama.2012.7352 DO - 10.1001/jama.2012.7352 ID - Neoptolemos2012 ER - TY - JOUR AU - Takada, T. AU - Nimura, Y. AU - Katoh, H. AU - Nagakawa, T. AU - Nakayama, T. AU - Matsushiro, T. PY - 1998 DA - 1998// TI - Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial JO - Hepatogastroenterology VL - 45 ID - Takada1998 ER - TY - JOUR AU - Primrose, J. N. AU - Fox, R. P. AU - Palmer, D. H. AU - Malik, H. Z. AU - Prasad, R. AU - Mirza, D. PY - 2019 DA - 2019// TI - Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study JO - Lancet Oncol VL - 20 UR - https://doi.org/10.1016/S1470-2045(18)30915-X DO - 10.1016/S1470-2045(18)30915-X ID - Primrose2019 ER - TY - JOUR AU - Sakuramoto, S. AU - Sasako, M. AU - Yamaguchi, T. AU - Kinoshita, T. AU - Fujii, M. AU - Nashimoto, A. PY - 2007 DA - 2007// TI - Adjuvant chemotherapy for gastric Cancer with S-1, an Oral Fluoropyrimidine JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMoa072252 DO - 10.1056/NEJMoa072252 ID - Sakuramoto2007 ER - TY - JOUR AU - Uesaka, K. AU - Boku, N. AU - Fukutomi, A. AU - Okamura, Y. AU - Konishi, M. AU - Matsumoto, I. PY - 2016 DA - 2016// TI - Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)30583-9 DO - 10.1016/S0140-6736(16)30583-9 ID - Uesaka2016 ER - TY - JOUR AU - Furuse, J. AU - Okusaka, T. AU - Boku, N. AU - Ohkawa, S. AU - Sawaki, A. AU - Masumoto, T. PY - 2008 DA - 2008// TI - S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study JO - Cancer Chemother Pharmacol VL - 62 UR - https://doi.org/10.1007/s00280-007-0673-7 DO - 10.1007/s00280-007-0673-7 ID - Furuse2008 ER - TY - JOUR AU - Kobayashi, S. AU - Nagano, H. AU - Tomokuni, A. AU - Gotoh, K. AU - Sakai, D. AU - Hatano, E. PY - 2019 DA - 2019// TI - A prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major hepatectomy for biliary tract Cancer (KHBO 1208): Kansai Hepato-biliary oncology group JO - Ann Surg VL - 270 UR - https://doi.org/10.1097/SLA.0000000000002865 DO - 10.1097/SLA.0000000000002865 ID - Kobayashi2019 ER - TY - JOUR AU - Nakachi, K. AU - Konishi, M. AU - Ikeda, M. AU - Mizusawa, J. AU - Eba, J. AU - Okusaka, T. PY - 2018 DA - 2018// TI - A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan clinical oncology group study (JCOG1202, ASCOT) JO - Jpn J Clin Oncol VL - 48 UR - https://doi.org/10.1093/jjco/hyy004 DO - 10.1093/jjco/hyy004 ID - Nakachi2018 ER - TY - JOUR AU - Yoshikawa, T. AU - Terashima, M. AU - Mizusawa, J. AU - Nunobe, S. AU - Nishida, Y. AU - Yamada, T. PY - 2019 DA - 2019// TI - Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial JO - Lancet Gastroenterol Hepatol VL - 4 UR - https://doi.org/10.1016/S2468-1253(18)30383-2 DO - 10.1016/S2468-1253(18)30383-2 ID - Yoshikawa2019 ER - TY - JOUR AU - Nakachi, K. AU - Konishi, M. AU - Ikeda, M. AU - Shimada, K. AU - Okusaka, T. AU - Saiura, A. PY - 2018 DA - 2018// TI - Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer JO - Int J Clin Oncol VL - 23 UR - https://doi.org/10.1007/s10147-018-1283-6 DO - 10.1007/s10147-018-1283-6 ID - Nakachi2018 ER - TY - BOOK AU - Bosman, F. T. AU - Carneiro, F. AU - Ralph, H. H. AU - Theise, N. D. PY - 2010 DA - 2010// TI - World Health Organization classification of Tumours of the digestive system PB - IARC CY - Lyon ID - Bosman2010 ER - TY - BOOK AU - Brierley, J. AU - Gospodarowicz, M. AU - Wittekind, C. PY - 2016 DA - 2016// TI - TNM classification of malignant tumours PB - Wiley-Blackwell CY - New York ID - Brierley2016 ER - TY - JOUR AU - Kinoshita, T. AU - Nashimoto, A. AU - Yamamura, Y. AU - Okamura, T. AU - Sasako, M. AU - Sakamoto, J. PY - 2004 DA - 2004// TI - Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer JO - Gastric Cancer VL - 7 UR - https://doi.org/10.1007/s10120-004-0278-3 DO - 10.1007/s10120-004-0278-3 ID - Kinoshita2004 ER - TY - JOUR AU - Kusumoto, T. AU - Ishiguro, M. AU - Nakatani, E. AU - Yoshida, M. AU - Inoue, T. AU - Nakamoto, Y. PY - 2018 DA - 2018// TI - Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer JO - ESMO Open VL - 3 UR - https://doi.org/10.1136/esmoopen-2018-000428 DO - 10.1136/esmoopen-2018-000428 ID - Kusumoto2018 ER - TY - JOUR AU - Ebata, T. AU - Hirano, S. AU - Konishi, M. AU - Uesaka, K. AU - Tsuchiya, Y. AU - Ohtsuka, M. PY - 2018 DA - 2018// TI - Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer JO - Br J Surg VL - 105 UR - https://doi.org/10.1002/bjs.10776 DO - 10.1002/bjs.10776 ID - Ebata2018 ER - TY - STD TI - Kano Y, Ohashi M, Hiki N, Takahari D, Chin K, Yamaguchi K, et al. Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists. Surg Today. 2020. https://doi.org/10.1007/s00595-020-01995-8. ID - ref22 ER - TY - JOUR AU - Okabe, H. AU - Kinjo, Y. AU - Obama, K. AU - Hosogi, H. AU - Hata, H. AU - Asao, Y. PY - 2019 DA - 2019// TI - A randomized phase II study of s-1 adjuvant chemotherapy with or without hochu-ekki-to, a japanese herbal medicine, for stage II/III gastric cancer: the kugc07 (shot) trial JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.00294 DO - 10.3389/fonc.2019.00294 ID - Okabe2019 ER -